Nevertheless, it was demonstrated that no expression of NKX2‐1/TTF‐1 exon 1 was frequently detected in EGFR and KRAS wild‐type tumours, suggesting that a tumour suppressive role of NKX2‐1_004 might be independent of such oncogenic alterations. The gene discussed is KRAS; the disease is neoplasm.